Publication details

Limited efficacy of daratumumab in multiple myeloma with extramedullary disease

Authors

JELINEK Tomas SEVCIKOVA Tereza ZIHALA David POPKOVA Tereza KAPUSTOVA Veronika BROSKEVICOVA Lucie CAPKOVA Lenka ŘÍHOVÁ Lucie BEZDĚKOVÁ Renata ŠEVČÍKOVÁ Sabina ZIDLIK Vladimir HAVEL Martin PLONKOVA Hana JUNGOVA Alexandra MINARIK Jiri ŠTORK Martin POUR Luděk PAVLICEK Petr SPICKA Ivan MAISNAR Vladimir RADOCHA Jakub SIMICEK Michal HAJEK Roman

Year of publication 2021
Type Article in Periodical
Magazine / Source Leukemia
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.nature.com/articles/s41375-021-01343-w
Doi http://dx.doi.org/10.1038/s41375-021-01343-w
Keywords daratumumab; multiple myeloma; extramedullary disease; efficacy
Description The treatment of multiple myeloma (MM) has changed substantially during the past two decades. The incorporation of novel agents into therapeutic strategies has resulted in prolonged overall survival of MM patients with approximately 15% of them being considered operationally cured.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info